Clone WT49 showed nuclear WT1 immunoreactivity in four (7.2%) lung carcinomas and in one (10.0%) synovial sarcoma, while clone 6F-H2 showed no nuclear immunoreactivity in any of the tumors, except for malignant pleural mesotheliomas. This evidence concerns the gene WT1 and lung carcinoma.